We have nothing new about Generex and CEPI but we

We have nothing new about Generex and CEPI but we have every reason to believe that Generex is still sorting through its 30+ peptides (developed in collaboration with EpiVax) to see which, either singly or in combination, has/have the capacity to evoke a covid19-specific immune response. Does anyone recall what the estimated end point will be for this efficacy testing? It seems like they went into the clinic three weeks ago but I could be wrong about that. I suppose if I were Joe I’d keep my covid pr powder dry until Antigen Express knows if it has any bullets to put in its gun. Perhaps CEPI (and BARDA) wants to know too before they pull their trigger. Not unreasonable.

So...we may not have any answers in that area for a while. In the interim I’d like an update on every else going on under the hood at Generex.